Gerhard Hindricks to Vitamin K
This is a "connection" page, showing publications Gerhard Hindricks has written about Vitamin K.
Connection Strength
0.175
-
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation. Europace. 2017 01; 19(1):132-138.
Score: 0.137
-
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Eur Heart J. 2018 08 21; 39(32):2942-2955.
Score: 0.038